Drug Profile
PF 6667291
Alternative Names: PF-6667291Latest Information Update: 03 Oct 2023
Price :
$50
*
At a glance
- Originator Pfizer
- Developer Pfizer; Tokyo Medical University
- Class Antineoplastics
- Mechanism of Action Janus kinase 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer